Cargando…

Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case–control study

PURPOSE: Ovarian cancer is the seventh most frequent form of malignant diseases in women worldwide and over 150,000 women die from it every year. More than 70 percent of all ovarian cancer patients are diagnosed at a late-stage disease with poor prognosis necessitating the development of sufficient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berner, Kai, Hirschfeld, Marc, Weiß, Daniela, Rücker, Gerta, Asberger, Jasmin, Ritter, Andrea, Nöthling, Claudia, Jäger, Markus, Juhasz-Böss, Ingolf, Erbes, Thalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Gynecologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300512/ https://www.ncbi.nlm.nih.gov/pubmed/34889994 http://dx.doi.org/10.1007/s00404-021-06287-1

Ejemplares similares

Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteins
por: Asberger, Jasmin, et al.
Publicado: (2020)

Circulating non-coding RNA-biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
por: Ritter, Andrea, et al.
Publicado: (2019)

Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitro
por: Klauser, Anna-Lena, et al.
Publicado: (2021)

In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer
por: Asberger, Jasmin, et al.
Publicado: (2023)

[(68)Ga]Ga-RM2 PET/CT reveals small distant metastases not detected by conventional imaging in primary estrogen receptor-positive breast cancer
por: Michalski, Kerstin, et al.
Publicado: (2023)

Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker
por: Erbes, Thalia, et al.
Publicado: (2015)

Prognostic value and management of regional lymph nodes in locoregional breast cancer recurrence: a systematic review of the literature
por: Ge, Isabell, et al.
Publicado: (2022)

Influences on pathologic complete response in breast cancer patients after neoadjuvant chemotherapy
por: Müller, Carolin, et al.
Publicado: (2021)

Factors influencing the time to surgery after neoadjuvant chemotherapy in breast cancer patients
por: Müller, Carolin, et al.
Publicado: (2020)

Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis
por: Huss, Alexandra, et al.
Publicado: (2022)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

Treatment of Cesarean Scar and Cervical Pregnancies Using the Ovum Aspiration Set for Intrachorial Methotrexate Injection as a Conservative, Fertility-Preserving Procedure
por: Ge, Isabell, et al.
Publicado: (2023)

Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform
por: Schaal, Kathrin, et al.
Publicado: (2015)

Evolving trends in the surgical therapy of patients with endometrial cancer in Germany: analysis of a nationwide registry with special emphasis on perioperative outcomes
por: Roth, Katrin, et al.
Publicado: (2023)

Integrated bioinformatic analysis of dysregulated microRNA‐mRNA co‐expression network in ovarian endometriosis
por: Liu, Yong, et al.
Publicado: (2022)

Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection
por: Erbes, Thalia, et al.
Publicado: (2014)

Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany
por: Neis, F., et al.
Publicado: (2022)

Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference
por: Mei, Shirley, et al.
Publicado: (2023)

MicroRNAs as Potential Serum Biomarkers for Early Detection of Ectopic Pregnancy
por: Kontomanolis, Emmanuel N, et al.
Publicado: (2018)

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

Executive Summary of the Ovarian Cancer Evidence Review Conference
por: Burke, William, et al.
Publicado: (2023)

Immunohistochemical assessment of PD-L1 expression using three different monoclonal antibodies in triple negative breast cancer patients
por: Schmidt, Gilda, et al.
Publicado: (2022)

Exometabolom analysis of breast cancer cell lines: Metabolic signature
por: Willmann, Lucas, et al.
Publicado: (2015)

The application of risk models based on machine learning to predict endometriosis‐associated ovarian cancer in patients with endometriosis
por: Chao, Xiaopei, et al.
Publicado: (2022)

The Importance of Extended Analysis Using Current Molecular Genetic Methods Based on the Example of a Cohort of 228 Patients with Hereditary Breast and Ovarian Cancer Syndrome
por: Resch, Luise D., et al.
Publicado: (2021)

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer
por: Stoian, Raluca, et al.
Publicado: (2023)

Navigating Unequal Paths: Racial Disparities in the Infertility Journey
por: Weiss, Marissa Steinberg, et al.
Publicado: (2023)

Efficacy of an optimal ovarian cancer screening: a best-case scenario study based on real-world data
por: Steinkasserer, Lena, et al.
Publicado: (2021)

Complete Laparoscopic Ovarian Cystectomy of Giant Ovarian Serous Cystadenoma
por: Prasad, Indira, et al.
Publicado: (2023)

Coexistence of Ovarian Endometrioma and Ovarian Pregnancy: A Case Report
por: Aoyagi, Yoko, et al.
Publicado: (2023)

Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis
por: Wolf, Jule, et al.
Publicado: (2022)

A Systematic Review Evaluating the Efficacy of Intra-Ovarian Infusion of Autologous Platelet-Rich Plasma in Patients With Poor Ovarian Reserve or Ovarian Insufficiency
por: Panda, Soumya R, et al.
Publicado: (2020)

HNRNP G and HTRA2-BETA1 regulate estrogen receptor alpha expression with potential impact on endometrial cancer
por: Hirschfeld, Marc, et al.
Publicado: (2015)

Evaluation of selected ultrasonographic parameters and marker levels in the preoperative differentiation of borderline ovarian tumors and ovarian cancers
por: Sobiczewski, Piotr, et al.
Publicado: (2012)

A Rare Presentation of Dual Ovarian Pathologies: Small Cell Carcinoma of the Ovary and Mucinous Ovarian Cancer
por: Mannan, Syed A, et al.
Publicado: (2021)

Circulating miR-200 family as predictive markers during systemic therapy of metastatic breast cancer
por: Fischer, Chiara, et al.
Publicado: (2022)

Early identification of recurrence in ovarian cancer: a comparison between the ovarian cancer metastasis index and CA-125 levels
por: Wang, Fei, et al.
Publicado: (2018)

Sensitivity and Specificity of Ultrasonography Using Ovarian-Adnexal Reporting and Data System Classification Versus Pathology Findings for Ovarian Cancer
por: Solis Cano, Dania Guadalupe, et al.
Publicado: (2021)

Kidney Carcinoma Ovarian Metastasis: Review of the Literature
por: Koufopoulos, Nektarios, et al.
Publicado: (2018)

Xanthogranulomatous Salpingo-Oophoritis Presenting as an Ovarian Malignancy
por: Manandhar, Tara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_okd4s9r7l51v9htpv4u51hh4a2